Loading clinical trials...

Evening Primrose Oil to Misoprostol During Induction of Second-trimester Missed Miscarriage | Clinical Trials | Clareo Health

COMPLETEDPHASE4

Evening Primrose Oil to Misoprostol During Induction of Second-trimester Missed Miscarriage

The Effect of Adding Vaginal Evening Primrose Oil to Misoprostol During Induction of Second-trimester Missed Miscarriage; a Randomized Controlled Trial

NCT03584698•Assiut University

View on ClinicalTrials.gov

Summary

Termination of pregnancy is an important subject that has complex and emotional controversies. The most common time of termination of pregnancy is the mid-trimester which has two-thirds of all serious abortion-related complications. There are many indications for mid trimester termination of pregnancy such as missed abortion, serious fetal abnormalities and lastly some women do not wish to continue a pregnancy and will often request termination of pregnancy

Eligibility

Age

All ages

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Nullipara or previous vaginal delivery only
•Bishop score was ≤ 5
•Women who will accept to participate in the study

Exclusion Criteria

•Multiple gestations
•Rupture of fetal membranes
•Previous cesarean sections
•Women with heavy bleeding
•Evidence of low implanted placenta by US
•Evidence of intra-uterine infection (either clinical or laboratory)

Locations (1)

Assiut Faculty of Medicine

Asyut, Egypt

Key Dates

Start Date

September 1, 2019

Primary Completion Date

January 15, 2021

Completion Date

March 31, 2021

Last Updated

April 26, 2021

Enrollment

144

ACTUAL participants

Conditions

Missed Abortion

Interventions

Misoprostol 100Mcg Tab

DRUG

Evening Primrose Oil 1000 MG

DRUG

Oxytocin Effectiveness in First Trimester Dilatation and Curettage

NCT06469203

Missed Abortion

View study

TERMINATEDPHASE4

Mifepristone and Misoprostol Versus Misoprostol Alone for Missed Abortion: A Randomized-controlled Trial

NCT02342002

Missed AbortionPregnancy

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 26, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions